戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ions, including HTLV-1-associated myelopathy/tropical spastic paraparesis.
2 ia/lymphoma and HTLV-1-associated myelopathy/tropical spastic paraparesis.
3 ll leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
4 ll leukemia and HTLV-1-associated myelopathy/tropical spastic paraparesis.
5 ogical disease, HTLV-I-associated myelopathy/tropical spastic paraparesis.
6 photropic virus type I-associated myelopathy/tropical spastic paraparesis.
7 photropic virus type I-associated myelopathy/tropical spastic paraparesis.
8 photropic virus type I-associated myelopathy/tropical spastic paraparesis.
9 isease known as HTLV-I-associated myelopathy/tropical spastic paraparesis.
10 phoma (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis.
11 cell leukemia and HTLV-I-associated myopathy/tropical spastic paraparesis.
12 l role in the pathology of HTLV-1-associated/tropical spastic paraparesis.
13 ll leukemia and HTLV-1-associated myelopathy/tropical spastic paraparesis.
14 nd lymphoma and HTLV-1-associated myelopathy-tropical spastic paraparesis.
15  those found in HTLV-I-associated myelopathy/tropical spastic paraparesis.
16 isease known as HTLV-1-associated myelopathy/tropical spastic paraparesis.
17 ia/lymphoma and HTLV-1 associated-myelopathy/tropical spastic paraparesis.
18 associated with HTLV-1-associated myelopathy/tropical spastic paraparesis?
19  cell leukemia virus-1-associated myelopathy/tropical spastic paraparesis, A6 also recognizes a self
20 ll leukemia and HTLV-1-associated myelopathy/tropical spastic paraparesis after the initial infection
21 tinct diseases: HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T cell leukemia.
22 n patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, and HTLV-1-associated uvei
23 ystem, HAM/TSP (HTLV-I-associated myelopathy/tropical spastic paraparesis), by reducing the proviral
24 s system (CNS), HTLV-I-associated myelopathy/tropical spastic paraparesis, characterized pathological
25 mmatory disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and adult T cell
26 iple sclerosis, HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) and chronic Lyme
27 ropic virus 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and multiple scle
28  virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and multiple scle
29  virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) are known to be c
30 ic virus (HTLV) type I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) based on newly de
31  virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) exhibit reduced F
32  I-associated (HTLV-I-associated) myelopathy/tropical spastic paraparesis (HAM/TSP) has been shown to
33  virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic neur
34  virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic, pro
35  virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a neurological
36  virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a progressive
37  virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an immune-medi
38  virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an inflammator
39  virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an inflammator
40  virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is associated wit
41 phoma (ATL) and HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) is poorly underst
42 ymphoma (ATLL) or HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) or develop a plet
43  virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) proliferate spont
44 n patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) results in a decr
45  development of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a chronic inflam
46  virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a disease that c
47 homa (ATLL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a progressive ne
48 HTLV-I) develop HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), an immune-mediat
49 e patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), mono- or oligocl
50 is the agent of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), observed in up t
51 d, resulting in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), or adult T cell
52 kemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
53 s system termed HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
54 ogical disorder HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
55  virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
56 kemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
57 kemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
58  disease termed HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
59 ase severity of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
60 l lymphotropic virus I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
61 kemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
62  disease called HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
63 f patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
64  disease termed HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
65 nd HTLV-1 associated myelopathy, also called tropical spastic paraparesis (HAM/TSP).
66 m patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
67 sease called HTLV-I-associated myelopathy or tropical spastic paraparesis (HAM/TSP).
68 matory disease, HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
69 ogical disease (HTLV-I-associated myelopathy/tropical spastic paraparesis [HAM/TSP]) is suggested to
70 photropic virus type I-associated myelopathy/tropical spastic paraparesis has been reported and is th
71 l p12(I) alleles found in ex vivo samples of tropical spastic paraparesis-HTLV-1-associated myelopath
72 apparent segregation of different alleles in tropical spastic paraparesis-HTLV-associated myelopathy
73 oma (ATL) and the neurodegenerative disorder tropical spastic paraparesis/HTLV-1-associated myelopath
74 of adult T-cell leukemia/lymphoma as well as tropical spastic paraparesis/HTLV-1-associated myelopath
75 uses both adult T-cell leukemia/lymphoma and tropical spastic paraparesis/HTLV-1-associated myelopath
76 es termed adult T-cell leukemia/lymphoma and tropical spastic paraparesis/HTLV-1-associated myelopath
77 -cell leukemia and the neurological disorder tropical spastic paraparesis/HTLV-I-associated myelopath
78 ological agent for adult T-cell leukemia and tropical spastic paraparesis/HTLV-I-associated myelopath
79  HTLV-I associated myelopathy (also known as tropical spastic paraparesis), infective dermatitis of c
80 photropic virus type I-associated myelopathy/tropical spastic paraparesis is a chronic progressive in
81  diseases, such as adult T-cell leukemia and tropical spastic paraparesis/myelopathy.
82 or patient with HTLV-1-associated myelopathy/tropical spastic paraparesis), ongoing infectious spread
83 ariety of clinical manifestations, including tropical spastic paraparesis or HTLV-1-associated myelop
84 photropic virus type I-associated myelopathy/tropical spastic paraparesis patients using real-time qu
85 l lymphotropic virus I-associated myelopathy/tropical spastic paraparesis, rheumatoid arthritis, mult
86  and determines HTLV-1-associated myelopathy/tropical spastic paraparesis risk.
87 n patients with HTLV-I-associated myelopathy/tropical spastic paraparesis suggest that HTLV-I may inf
88 ndividuals with HTLV-1-associated myelopathy/tropical spastic paraparesis than in 29 asymptomatic car
89 ) causing HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP)] and subcortical isch
90 sis showed that HTLV-1-associated myelopathy/tropical spastic paraparesis was associated with a lower
91 mmatory disease HTLV-1-associated myelopathy/tropical spastic paraparesis was associated with signifi